共 16 条
[1]
A 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitor reduces hypertensive nephrosclerosis in stroke-prone spontaneously hypertensive rats. Yamashita T,Kawashima S,Miwa Y,et al. Journal of Hypertension . 2002
[2]
HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Usui H,Shikata K,Matsuda M,et al. Nephrology Dialysis Transplantation . 2003
[3]
Buemi M,Allegra A,Corica F,et al. Clinical Pharmacology and Therapeutics . 2000
[4]
Atherogenic lipoproteins and diabetes mellitus. Yoshino G,Hirano T,Kazumi T. Journal of Diabetes and Its Complications . 2002
[5]
Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Zoja Carla,Corna Daniela,Rottoli Daniela,et al. Kidney International . 2002
[6]
Effects of atorvastatin on ischemic acute renal failure in aging rats. Pisani A,Uccello F,Cesaro A,et al. Giornale Italiano Di Nefrologia . 2002
[7]
Are there potential non-lipid-lowering uses of statins. Wheeler DC. Drugs . 1998
[8]
Kidney and statins. Moulin B,Cailard S. Annales d Endocrinologie . 2001
[9]
Statins and renal function. Elisaf M,Mikhailids DP. Angiology . 2002
[10]
Are there potential non-lipidlowering uses of statins in the kidney. Buemi M,Senatore M,Corica F,et al. Nephron . 2001